OR WAIT 15 SECS
© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
July 11, 2019
A look at recent developments in treatment and the cost implications of various autoimmune diseases.
January 01, 2019
Autoimmune diseases often impact many organ systems and are complex, requiring a number of specialists to manage them. Here’s a snapshot of an interesting new model that addresses care challenges of these diseases.
Most autoimmune diseases don’t have cures. Here are the top ways providers can manage and control them.
December 13, 2018
Here’s a look at three innovative drugs used to treat autoimmune conditions that made the news this year.
Because of the inflammatory nature of psoriasis, biologics are good drug candidates, but could affect cost and reimbursement.
December 01, 2018
There has been an increase in the number of people with autoimmune diseases. Here’s what you should know about them.
Autoimmune patients suffer a variety of comorbidities and often require extra care-here’s how the costs of that care can be reduced.
November 07, 2018
October 19, 2018
Managing psoriasis can be difficult for a variety of reasons. Here’s a look at the top six challenges that experts identified.
Individuals with immune-mediated diseases, such as psoriasis, are at higher risk for having other immune-mediated diseases. Here’s how psoriasis can lead to other conditions, and the associated costs.
April 25, 2018
March 29, 2018
PBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.
February 01, 2018
Health systems realize that telehealth can help them achieve a wide range of objectives, from care coordination to readmission avoidance and market share expansion.
January 06, 2018
This might be the year when it becomes clear, perhaps painfully so, whether or not biosimilars can deliver on cost savings expectations.
August 24, 2017
Allegheny Health Network’s Susan Manzi, MD, MPH, discusses the healthcare needs of patients with lupus and other autoimmune disorders.
May 06, 2017
New drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease-some recently approved and others coming down the pipeline-could have an impact on the industry.
January 03, 2017
Find out about the latest treatment and drug pipeline developments
November 29, 2016
Here’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.